Joint pulmonologist and ENT consult for asthma with nasal polyps care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines a coordinated care approach for patients who have both asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). Participants receive a joint consultation by a pulmonologist and an ENT specialist, along with nasal and mucus sampling. The goal is to see if this integrated visit leads to less reliance on systemic corticosteroids over the following 12 months by enabling more personalized treatment plans. Secondary outcomes (not fully detailed) may include changes in symptom control and other clinical endpoints. The study is conducted at AP-HM in Marseille, France, and targets adults with uncontrolled disease despite prior systemic corticosteroid use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or female, 18 years of age or older;
* With a diagnosis of asthma;
* With a diagnosis of chronic rhinosinusitis with nasal polyposis;
* Whose asthma and/or chronic rhinosinusitis is/are not controlled according to SNOT-22 and ACQ-6 scores;
* Having used systemic corticosteroids in the previous year to treat symptoms related to one of these conditions at least;

Exclusion Criteria:

* Patient in a period of exclusion from another research protocol at the time of consent signature;
* Subjects covered by articles L1121-5 to 1121-8 of the French Public Health Code (adult patients under guardianship or curatorship, patients deprived of their liberty, pregnant or breast-feeding women);
* Patients who do not read and/or understand French

Where it's running

• Ap-Hm
  Marseille, France Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Real-world use of tezepelumab for chronic rhinosinusitis with nasal polyps in Russia

  This study will see how tezepelumab works in adults in Russia who have chronic rhinosinusitis with nasal polyps, with or without asthma.

  Recruiting at 10 sites AstraZeneca · Kazan' and 9 other locations · NCT07399665

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• HB0056 in adults with moderate to severe asthma

  This study tests HB0056 versus a placebo to see if it helps adults with moderate to severe asthma reduce rescue inhaler use and improve symptoms.

  Recruiting at 2 sites Phase 1/2 Shanghai Huaota Biopharmaceutical Co., Ltd. · Beijing and 1 other locations · NCT07899996

• Tilrekimig (PF-07275315) for Severe Asthma: Aimed at Adults with Frequent Exacerbations

  This study tests whether tilrekimig helps people with severe asthma who have had multiple flare-ups in the past year, by comparing it to a placebo given every four weeks.

  Recruiting at 4 sites Phase 3 Pfizer · River Forest, Illinois and 11 other locations · NCT07869043

• Metabolic and Immunologic Biomarkers in Chronic Rhinosinusitis with Nasal Polyps

  This study tests whether metabolic and immune markers in nasal tissue and blood differ between people with nasal polyps and those without, to help understand CRSwNP and find potential diagnostic clues.

  Recruiting Harran University · Sanliurfa, Şanlıurfa · NCT07860411

• Inhaled CHF10136 safety and pharmacokinetics in healthy adults and adults with asthma

  This first-in-human study tests inhaled CHF10136 to see if it is safe and well tolerated, how it behaves in the body, and how it affects adults with asthma compared with placebo.

  Recruiting Phase 1 Chiesi Farmaceutici S.p.A. · Leeds and 2 other locations · NCT07851623

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.